speb/financial-data huggingface dataset:
CRVO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 6666338.00
CRVO balance_sheet (annual, 2022-12-31) — Capital Stock: 518.00
CRVO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 4093579.00
CRVO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 4093579.00
CRVO balance_sheet (annual, 2022-12-31) — Cash Equivalents: 4093579.00
CRVO balance_sheet (annual, 2022-12-31) — Cash Financial: 1586920.00
CRVO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 0.00
CRVO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -12235738.00
CRVO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -2572759.00
CRVO cash_flow (annual, 2022-12-31) — Change In Account Payable: 79154.00
CRVO cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 215679.00
CRVO cash_flow (annual, 2022-12-31) — Change In Payable: 79154.00
CRVO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 294833.00
CRVO cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 85104.00
CRVO cash_flow (annual, 2022-12-31) — Change In Receivables: 0.00
CRVO cash_flow (annual, 2022-12-31) — Change In Working Capital: 379937.00
CRVO cash_flow (annual, 2022-12-31) — Changes In Cash: -2572759.00
CRVO balance_sheet (annual, 2022-12-31) — Common Stock: 518.00
CRVO balance_sheet (annual, 2022-12-31) — Common Stock Equity: -33285059.00
CRVO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
CRVO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 280182.00
CRVO balance_sheet (annual, 2022-12-31) — Current Assets: 4157706.00
CRVO balance_sheet (annual, 2022-12-31) — Current Debt: 12414000.00
CRVO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 12414000.00
CRVO balance_sheet (annual, 2022-12-31) — Current Liabilities: 13155554.00
CRVO cash_flow (annual, 2022-12-31) — Deferred Income Tax: 0.00
CRVO cash_flow (annual, 2022-12-31) — Deferred Tax: 0.00
CRVO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 0.00
CRVO income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 0.00
CRVO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 0.00
CRVO income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 0.00
CRVO income_statement (annual, 2022-12-31) — Depreciation Income Statement: 0.00
CRVO income_statement (annual, 2022-12-31) — Diluted Average Shares: 518140.00
CRVO income_statement (annual, 2022-12-31) — Diluted EPS: -11.20
CRVO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -5803047.00
CRVO income_statement (annual, 2022-12-31) — EBIT: -5802460.00
CRVO income_statement (annual, 2022-12-31) — EBITDA: -5802460.00
CRVO cash_flow (annual, 2022-12-31) — End Cash Position: 4093579.00
CRVO cash_flow (annual, 2022-12-31) — Financing Cash Flow: 0.00
CRVO cash_flow (annual, 2022-12-31) — Free Cash Flow: -2572759.00
CRVO cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 0.00
CRVO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -35375.00
CRVO income_statement (annual, 2022-12-31) — General And Administrative Expense: 2139065.00
CRVO income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
CRVO income_statement (annual, 2022-12-31) — Interest Expense: 587.00
CRVO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 587.00
CRVO income_statement (annual, 2022-12-31) — Interest Income: 62226.00
CRVO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 62226.00
CRVO balance_sheet (annual, 2022-12-31) — Invested Capital: -20871059.00
CRVO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -12235738.00
CRVO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CRVO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
CRVO balance_sheet (annual, 2022-12-31) — Net Debt: 8320421.00
CRVO income_statement (annual, 2022-12-31) — Net Income: -5803047.00
CRVO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -5803047.00
CRVO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -5803047.00
CRVO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -5803047.00
CRVO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -5803047.00
CRVO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -5803047.00
CRVO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -5803047.00
CRVO income_statement (annual, 2022-12-31) — Net Interest Income: 61639.00
CRVO cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -12235738.00
CRVO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 61639.00
CRVO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 0.00
CRVO cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 5000.00
CRVO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -33285059.00
CRVO income_statement (annual, 2022-12-31) — Normalized EBITDA: -5802460.00
CRVO income_statement (annual, 2022-12-31) — Normalized Income: -5803047.00
CRVO cash_flow (annual, 2022-12-31) — Operating Cash Flow: -2572759.00
CRVO cash_flow (annual, 2022-12-31) — Operating Gains Losses: 127516.00
CRVO income_statement (annual, 2022-12-31) — Operating Income: -3475534.00
CRVO income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
CRVO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 1359704.00
CRVO balance_sheet (annual, 2022-12-31) — Other Current Assets: 112406.00
CRVO balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 12414000.00
CRVO balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 129851.00
CRVO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -35375.00
CRVO income_statement (annual, 2022-12-31) — Other Gand A: 2139065.00
CRVO income_statement (annual, 2022-12-31) — Other Income Expense: -2389152.00
CRVO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -2389152.00
CRVO balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 12408940.00
CRVO balance_sheet (annual, 2022-12-31) — Payables: 97302.00
CRVO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 377484.00
CRVO cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: 127516.00
CRVO balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 364070.00
CRVO balance_sheet (annual, 2022-12-31) — Preferred Securities Outside Stock Equity: 24287211.00
CRVO cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 5000.00
CRVO balance_sheet (annual, 2022-12-31) — Prepaid Assets: 64127.00
CRVO income_statement (annual, 2022-12-31) — Pretax Income: -5803047.00
CRVO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
CRVO cash_flow (annual, 2022-12-31) — Purchase Of Investment: -37985738.00
CRVO balance_sheet (annual, 2022-12-31) — Receivables: 0.00
CRVO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 0.00
CRVO income_statement (annual, 2022-12-31) — Research And Development: 1336469.00
CRVO balance_sheet (annual, 2022-12-31) — Retained Earnings: -52268916.00
CRVO cash_flow (annual, 2022-12-31) — Sale Of Investment: 25750000.00
CRVO cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
CRVO income_statement (annual, 2022-12-31) — Selling General And Administration: 2139065.00
CRVO balance_sheet (annual, 2022-12-31) — Share Issued: 1359704.00
CRVO income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
CRVO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 333835.00
CRVO balance_sheet (annual, 2022-12-31) — Stockholders Equity: -33285059.00
CRVO balance_sheet (annual, 2022-12-31) — Tangible Book Value: -33285059.00
CRVO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CRVO income_statement (annual, 2022-12-31) — Tax Provision: 0.00
CRVO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
CRVO balance_sheet (annual, 2022-12-31) — Total Assets: 4157706.00
CRVO balance_sheet (annual, 2022-12-31) — Total Capitalization: -33285059.00
CRVO balance_sheet (annual, 2022-12-31) — Total Debt: 12414000.00
CRVO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -33285059.00
CRVO income_statement (annual, 2022-12-31) — Total Expenses: 3475534.00
CRVO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 37442765.00
CRVO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 0.00
CRVO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 24287211.00
CRVO income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -3475534.00
CRVO balance_sheet (annual, 2022-12-31) — Total Tax Payable: 0.00
CRVO income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
CRVO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CRVO cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 2389000.00
CRVO balance_sheet (annual, 2022-12-31) — Working Capital: -8997848.00
CRVO income_statement (annual, 2023-12-31) — +Operating Expense: 7812895.00
CRVO income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
CRVO balance_sheet (annual, 2023-12-31) — Accounts Payable: 662471.00
CRVO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 61811889.00
CRVO cash_flow (annual, 2023-12-31) — Amortization Of Securities: 0.00
CRVO income_statement (annual, 2023-12-31) — Basic Average Shares: 2661416.00
CRVO income_statement (annual, 2023-12-31) — Basic EPS: -0.82
CRVO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 4093579.00
CRVO balance_sheet (annual, 2023-12-31) — Capital Stock: 5674.00
CRVO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 7792846.00
CRVO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 7792846.00
CRVO balance_sheet (annual, 2023-12-31) — Cash Equivalents: 7792846.00
CRVO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 11149114.00
CRVO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 0.00
CRVO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -7449847.00
CRVO cash_flow (annual, 2023-12-31) — Change In Account Payable: 565169.00
CRVO cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 1289024.00
CRVO cash_flow (annual, 2023-12-31) — Change In Payable: 565169.00
CRVO cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 1854193.00
CRVO cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -1200144.00
CRVO cash_flow (annual, 2023-12-31) — Change In Receivables: -915404.00
CRVO cash_flow (annual, 2023-12-31) — Change In Working Capital: -261355.00
CRVO cash_flow (annual, 2023-12-31) — Changes In Cash: 3699267.00
CRVO balance_sheet (annual, 2023-12-31) — Common Stock: 5674.00
CRVO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 7376774.00
CRVO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 810000.00
CRVO balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 698107.00
CRVO balance_sheet (annual, 2023-12-31) — Current Assets: 9964751.00
CRVO balance_sheet (annual, 2023-12-31) — Current Liabilities: 2595747.00
CRVO income_statement (annual, 2023-12-31) — Diluted Average Shares: 2661416.00
CRVO income_statement (annual, 2023-12-31) — Diluted EPS: -0.82
CRVO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -2171873.00
CRVO income_statement (annual, 2023-12-31) — EBIT: -7812895.00
CRVO income_statement (annual, 2023-12-31) — EBITDA: -7812895.00
CRVO cash_flow (annual, 2023-12-31) — End Cash Position: 7792846.00
CRVO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 11149114.00
CRVO cash_flow (annual, 2023-12-31) — Free Cash Flow: -7449847.00
CRVO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 0.00
CRVO income_statement (annual, 2023-12-31) — General And Administrative Expense: 6519268.00
CRVO income_statement (annual, 2023-12-31) — Interest Expense: 0.00
CRVO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 0.00
CRVO income_statement (annual, 2023-12-31) — Interest Income: 219430.00
CRVO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 219430.00
CRVO balance_sheet (annual, 2023-12-31) — Invested Capital: 7376774.00
CRVO cash_flow (annual, 2023-12-31) — Investing Cash Flow: 0.00
CRVO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 810000.00
CRVO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 810000.00
CRVO income_statement (annual, 2023-12-31) — Net Income: -2171873.00
CRVO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -2171873.00
CRVO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -2171873.00
CRVO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -2171873.00
CRVO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -2171873.00
CRVO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -2171873.00
CRVO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -2171873.00
CRVO income_statement (annual, 2023-12-31) — Net Interest Income: 219430.00
CRVO cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 0.00
CRVO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 219430.00
CRVO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 10339114.00
CRVO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 7376774.00
CRVO income_statement (annual, 2023-12-31) — Normalized EBITDA: -7812895.00
CRVO income_statement (annual, 2023-12-31) — Normalized Income: -2171873.00
CRVO cash_flow (annual, 2023-12-31) — Operating Cash Flow: -7449847.00
CRVO income_statement (annual, 2023-12-31) — Operating Income: -7812895.00
CRVO income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
CRVO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 5674520.00
CRVO balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 88659.00
CRVO income_statement (annual, 2023-12-31) — Other Gand A: 6519268.00
CRVO income_statement (annual, 2023-12-31) — Other Income Expense: 5421592.00
CRVO balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 7770.00
CRVO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 5421592.00
CRVO income_statement (annual, 2023-12-31) — Other Operating Expenses: -7144872.00
CRVO balance_sheet (annual, 2023-12-31) — Other Receivables: 915404.00
CRVO balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 0.00
CRVO balance_sheet (annual, 2023-12-31) — Payables: 782927.00
CRVO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 1481034.00
CRVO cash_flow (annual, 2023-12-31) — Pension And Employee Benefit Expense: 0.00
CRVO balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1026054.00
CRVO balance_sheet (annual, 2023-12-31) — Preferred Securities Outside Stock Equity: 0.00
CRVO balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CRVO balance_sheet (annual, 2023-12-31) — Prepaid Assets: 1256501.00
CRVO income_statement (annual, 2023-12-31) — Pretax Income: -2171873.00
CRVO cash_flow (annual, 2023-12-31) — Purchase Of Investment: 0.00
CRVO balance_sheet (annual, 2023-12-31) — Receivables: 915404.00
CRVO income_statement (annual, 2023-12-31) — Research And Development: 8438499.00
CRVO balance_sheet (annual, 2023-12-31) — Retained Earnings: -54440789.00
CRVO cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
CRVO income_statement (annual, 2023-12-31) — Selling General And Administration: 6519268.00
CRVO balance_sheet (annual, 2023-12-31) — Share Issued: 5674520.00
CRVO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 407632.00
CRVO balance_sheet (annual, 2023-12-31) — Stockholders Equity: 7376774.00
CRVO balance_sheet (annual, 2023-12-31) — Tangible Book Value: 7376774.00
CRVO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CRVO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
CRVO balance_sheet (annual, 2023-12-31) — Total Assets: 9972521.00
CRVO balance_sheet (annual, 2023-12-31) — Total Capitalization: 7376774.00
CRVO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 7376774.00
CRVO income_statement (annual, 2023-12-31) — Total Expenses: 7812895.00
CRVO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 2595747.00
CRVO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 7770.00
CRVO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CRVO income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -7812895.00
CRVO balance_sheet (annual, 2023-12-31) — Total Tax Payable: 120456.00
CRVO cash_flow (annual, 2023-12-31) — Unrealized Gain Loss On Investment Securities: -5424251.00
CRVO balance_sheet (annual, 2023-12-31) — Working Capital: 7369004.00
CRVO income_statement (quarterly, 2024-09-30) — Average Dilution Earnings: 0.00
CRVO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 8702764.00
CRVO income_statement (quarterly, 2024-09-30) — Basic EPS: -0.55
CRVO cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: -13340.00
CRVO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 8702764.00
CRVO income_statement (quarterly, 2024-09-30) — Diluted EPS: -0.55
CRVO cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: -13340.00
CRVO cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: -13340.00
CRVO balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 1888879.00
CRVO balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 73937.00
CRVO cash_flow (quarterly, 2024-09-30) — Unrealized Gain Loss On Investment Securities: 0.00
CRVO income_statement (annual, 2024-12-31) — +Operating Expense: 18227131.00
CRVO income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
CRVO balance_sheet (annual, 2024-12-31) — Accounts Payable: 1511440.00
CRVO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 109868913.00
CRVO cash_flow (annual, 2024-12-31) — Amortization Of Securities: -1205197.00
CRVO income_statement (annual, 2024-12-31) — Basic Average Shares: 8073155.00
CRVO income_statement (annual, 2024-12-31) — Basic EPS: -2.02
CRVO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 7792846.00
CRVO balance_sheet (annual, 2024-12-31) — Capital Stock: 8702.00
CRVO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 8999496.00
CRVO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 38922019.00
CRVO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 46398606.00
CRVO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -28661129.00
CRVO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -16530827.00
CRVO cash_flow (annual, 2024-12-31) — Change In Account Payable: 848969.00
CRVO cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 690290.00
CRVO cash_flow (annual, 2024-12-31) — Change In Payable: 848969.00
CRVO cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 1539259.00
CRVO cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -641089.00
CRVO cash_flow (annual, 2024-12-31) — Change In Receivables: -1338827.00
CRVO cash_flow (annual, 2024-12-31) — Change In Working Capital: -440657.00
CRVO cash_flow (annual, 2024-12-31) — Changes In Cash: 1206650.00
CRVO balance_sheet (annual, 2024-12-31) — Common Stock: 8702.00
CRVO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 39202328.00
CRVO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 46398606.00
CRVO cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
CRVO balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 1408310.00
CRVO balance_sheet (annual, 2024-12-31) — Current Assets: 43081610.00
CRVO balance_sheet (annual, 2024-12-31) — Current Deferred Assets: 0.00
CRVO balance_sheet (quarterly, 2024-12-31) — Current Deferred Assets: 0.00
CRVO balance_sheet (annual, 2024-12-31) — Current Liabilities: 3879282.00
CRVO income_statement (annual, 2024-12-31) — Diluted Average Shares: 8073155.00
CRVO income_statement (annual, 2024-12-31) — Diluted EPS: -2.02
CRVO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -16290695.00
CRVO income_statement (annual, 2024-12-31) — EBIT: -18227131.00
CRVO income_statement (annual, 2024-12-31) — EBITDA: -18227131.00
CRVO cash_flow (annual, 2024-12-31) — End Cash Position: 8999496.00
CRVO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 46398606.00
CRVO cash_flow (annual, 2024-12-31) — Free Cash Flow: -16530827.00
CRVO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 56197.00
CRVO income_statement (annual, 2024-12-31) — General And Administrative Expense: 9166762.00
CRVO income_statement (annual, 2024-12-31) — Interest Income: 1937427.00
CRVO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 1937427.00
CRVO balance_sheet (annual, 2024-12-31) — Invested Capital: 39202328.00
CRVO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -28661129.00
CRVO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 46398606.00
CRVO cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
CRVO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 46398606.00
CRVO cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
CRVO income_statement (annual, 2024-12-31) — Net Income: -16290695.00
CRVO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -16290695.00
CRVO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -16290695.00
CRVO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -16290695.00
CRVO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -16290695.00
CRVO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -16290695.00
CRVO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -16290695.00
CRVO income_statement (annual, 2024-12-31) — Net Interest Income: 1937427.00
CRVO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -28661129.00
CRVO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 1937427.00
CRVO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 39202328.00
CRVO income_statement (annual, 2024-12-31) — Normalized EBITDA: -18227131.00
CRVO income_statement (annual, 2024-12-31) — Normalized Income: -16290695.00
CRVO cash_flow (annual, 2024-12-31) — Operating Cash Flow: -16530827.00
CRVO income_statement (annual, 2024-12-31) — Operating Income: -18227131.00
CRVO income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
CRVO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 8702719.00
CRVO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 115883.00
CRVO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 56197.00
CRVO income_statement (annual, 2024-12-31) — Other Gand A: 9166762.00
CRVO income_statement (annual, 2024-12-31) — Other Income Expense: -991.00
CRVO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -991.00
CRVO income_statement (annual, 2024-12-31) — Other Operating Expenses: -9737974.00
CRVO income_statement (quarterly, 2024-12-31) — Other Operating Expenses: -2162002.00
CRVO balance_sheet (annual, 2024-12-31) — Other Receivables: 2254231.00
CRVO balance_sheet (quarterly, 2024-12-31) — Other Receivables: 2254231.00
CRVO balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 29922523.00
CRVO balance_sheet (annual, 2024-12-31) — Payables: 1551896.00
CRVO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 2960206.00
CRVO balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 803193.00
CRVO balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CRVO balance_sheet (annual, 2024-12-31) — Prepaid Assets: 1905360.00
CRVO balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 1905360.00
CRVO income_statement (annual, 2024-12-31) — Pretax Income: -16290695.00
CRVO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -48101129.00
CRVO balance_sheet (annual, 2024-12-31) — Receivables: 2254231.00
CRVO income_statement (annual, 2024-12-31) — Research And Development: 18798343.00
CRVO balance_sheet (annual, 2024-12-31) — Retained Earnings: -70731484.00
CRVO cash_flow (annual, 2024-12-31) — Sale Of Investment: 19440000.00
CRVO income_statement (annual, 2024-12-31) — Selling General And Administration: 9166762.00
CRVO balance_sheet (annual, 2024-12-31) — Share Issued: 8702719.00
CRVO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1405722.00
CRVO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 39202328.00
CRVO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 39202328.00
CRVO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CRVO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
CRVO balance_sheet (annual, 2024-12-31) — Total Assets: 43081610.00
CRVO balance_sheet (annual, 2024-12-31) — Total Capitalization: 39202328.00
CRVO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 39202328.00
CRVO income_statement (annual, 2024-12-31) — Total Expenses: 18227131.00
CRVO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 3879282.00
CRVO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 0.00
CRVO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CRVO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -18227131.00
CRVO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 40456.00
CRVO cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
CRVO cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
CRVO balance_sheet (annual, 2024-12-31) — Working Capital: 39202328.00
CRVO income_statement (quarterly, 2025-03-31) — +Operating Expense: 5302884.00
CRVO income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
CRVO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1860598.00
CRVO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 110230080.00
CRVO cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -251828.00
CRVO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 8702719.00
CRVO income_statement (quarterly, 2025-03-31) — Basic EPS: -0.56
CRVO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 8999496.00
CRVO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 8702.00
CRVO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 10501714.00
CRVO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 35244514.00
CRVO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 0.00
CRVO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 5396577.00
CRVO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -3894359.00
CRVO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 349158.00
CRVO cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -285439.00
CRVO cash_flow (quarterly, 2025-03-31) — Change In Payable: 349158.00
CRVO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 63719.00
CRVO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 201613.00
CRVO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 625004.00
CRVO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 890336.00
CRVO cash_flow (quarterly, 2025-03-31) — Changes In Cash: 1502218.00
CRVO balance_sheet (quarterly, 2025-03-31) — Common Stock: 8702.00
CRVO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 34634487.00
CRVO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 1535046.00
CRVO balance_sheet (quarterly, 2025-03-31) — Current Assets: 38577488.00
CRVO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 3943001.00
CRVO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 8702719.00
CRVO income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.56
CRVO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -4894034.00
CRVO income_statement (quarterly, 2025-03-31) — EBIT: -5302884.00
CRVO income_statement (quarterly, 2025-03-31) — EBITDA: -5302884.00
CRVO cash_flow (quarterly, 2025-03-31) — End Cash Position: 10501714.00
CRVO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 0.00
CRVO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -3894359.00
CRVO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 21223.00
CRVO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 2382577.00
CRVO income_statement (quarterly, 2025-03-31) — Insurance And Claims: 219586.00
CRVO income_statement (quarterly, 2025-03-31) — Interest Income: 408985.00
CRVO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 408985.00
CRVO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 34634487.00
CRVO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 5396577.00
CRVO income_statement (quarterly, 2025-03-31) — Net Income: -4894034.00
CRVO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -4894034.00
CRVO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -4894034.00
CRVO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -4894034.00
CRVO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -4894034.00
CRVO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -4894034.00
CRVO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -4894034.00
CRVO income_statement (quarterly, 2025-03-31) — Net Interest Income: 408985.00
CRVO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 5396577.00
CRVO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 408985.00
CRVO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 34634487.00
CRVO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -5302884.00
CRVO income_statement (quarterly, 2025-03-31) — Normalized Income: -4894034.00
CRVO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -3894359.00
CRVO income_statement (quarterly, 2025-03-31) — Operating Income: -5302884.00
CRVO income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
CRVO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 8702719.00
CRVO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 1703747.00
CRVO balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 102511.00
CRVO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 21223.00
CRVO income_statement (quarterly, 2025-03-31) — Other Gand A: 814432.00
CRVO income_statement (quarterly, 2025-03-31) — Other Income Expense: -135.00
CRVO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -135.00
CRVO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -1917491.00
CRVO balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1629227.00
CRVO balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 24742800.00
CRVO balance_sheet (quarterly, 2025-03-31) — Payables: 1919578.00
CRVO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 3454624.00
CRVO balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 385866.00
CRVO balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CRVO income_statement (quarterly, 2025-03-31) — Pretax Income: -4894034.00
CRVO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
CRVO cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -7103423.00
CRVO balance_sheet (quarterly, 2025-03-31) — Receivables: 1629227.00
CRVO income_statement (quarterly, 2025-03-31) — Research And Development: 4837798.00
CRVO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -75625518.00
CRVO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 1348559.00
CRVO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 12500000.00
CRVO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2382577.00
CRVO balance_sheet (quarterly, 2025-03-31) — Share Issued: 8702719.00
CRVO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 361167.00
CRVO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 34634487.00
CRVO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 34634487.00
CRVO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CRVO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
CRVO balance_sheet (quarterly, 2025-03-31) — Total Assets: 38577488.00
CRVO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 34634487.00
CRVO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 34634487.00
CRVO income_statement (quarterly, 2025-03-31) — Total Expenses: 5302884.00
CRVO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 3943001.00
CRVO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 0.00
CRVO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
CRVO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -5302884.00
CRVO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 58980.00
CRVO balance_sheet (quarterly, 2025-03-31) — Working Capital: 34634487.00
CRVO income_statement (quarterly, 2025-06-30) — +Operating Expense: 6616275.00
CRVO income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
CRVO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1845609.00
CRVO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 115315232.00
CRVO cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -234666.00
CRVO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 9252719.00
CRVO income_statement (quarterly, 2025-06-30) — Basic EPS: -0.84
CRVO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 10501714.00
CRVO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 9252.00
CRVO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 8320713.00
CRVO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 33531166.00
CRVO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 4588687.00
CRVO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -254993.00
CRVO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -6514695.00
CRVO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -76566.00
CRVO cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 713608.00
CRVO cash_flow (quarterly, 2025-06-30) — Change In Payable: -76566.00
CRVO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 637042.00
CRVO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -260580.00
CRVO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -731748.00
CRVO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -518640.00
CRVO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -2181001.00
CRVO balance_sheet (quarterly, 2025-06-30) — Common Stock: 9252.00
CRVO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 33439779.00
CRVO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 1389964.00
CRVO balance_sheet (quarterly, 2025-06-30) — Current Assets: 38081399.00
CRVO balance_sheet (quarterly, 2025-06-30) — Current Deferred Assets: 224931.00
CRVO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 4641620.00
CRVO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 9252719.00
CRVO income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.84
CRVO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -6258404.00
CRVO income_statement (quarterly, 2025-06-30) — EBIT: -6616275.00
CRVO income_statement (quarterly, 2025-06-30) — EBITDA: -6616275.00
CRVO cash_flow (quarterly, 2025-06-30) — End Cash Position: 8320713.00
CRVO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 4588687.00
CRVO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -6514695.00
CRVO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -783.00
CRVO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 3265374.00
CRVO income_statement (quarterly, 2025-06-30) — Interest Income: 368127.00
CRVO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 368127.00
CRVO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 33439779.00
CRVO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -254993.00
CRVO income_statement (quarterly, 2025-06-30) — Net Income: -6258404.00
CRVO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -6258404.00
CRVO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -6258404.00
CRVO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -6258404.00
CRVO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -6258404.00
CRVO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -6258404.00
CRVO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -6258404.00
CRVO income_statement (quarterly, 2025-06-30) — Net Interest Income: 368127.00
CRVO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -254993.00
CRVO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 368127.00
CRVO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 33439779.00
CRVO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -6616275.00
CRVO income_statement (quarterly, 2025-06-30) — Normalized Income: -6258404.00
CRVO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -6514695.00
CRVO income_statement (quarterly, 2025-06-30) — Operating Income: -6616275.00
CRVO income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
CRVO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 8702719.00
CRVO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1964327.00
CRVO balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 83684.00
CRVO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -783.00
CRVO income_statement (quarterly, 2025-06-30) — Other Gand A: 3265374.00
CRVO income_statement (quarterly, 2025-06-30) — Other Income Expense: -10256.00
CRVO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -10256.00
CRVO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: -1757724.00
CRVO balance_sheet (quarterly, 2025-06-30) — Other Receivables: 2360975.00
CRVO balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 25210453.00
CRVO balance_sheet (quarterly, 2025-06-30) — Payables: 1866065.00
CRVO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 3256029.00
CRVO balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 1301907.00
CRVO balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CRVO income_statement (quarterly, 2025-06-30) — Pretax Income: -6258404.00
CRVO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -9754993.00
CRVO balance_sheet (quarterly, 2025-06-30) — Receivables: 2360975.00
CRVO income_statement (quarterly, 2025-06-30) — Research And Development: 5108625.00
CRVO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -81883922.00
CRVO cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 9500000.00
CRVO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 3265374.00
CRVO balance_sheet (quarterly, 2025-06-30) — Share Issued: 8702719.00
CRVO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 497015.00
CRVO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 33439779.00
CRVO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 33439779.00
CRVO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CRVO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
CRVO balance_sheet (quarterly, 2025-06-30) — Total Assets: 38081399.00
CRVO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 33439779.00
CRVO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 33439779.00
CRVO income_statement (quarterly, 2025-06-30) — Total Expenses: 6616275.00
CRVO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 4641620.00
CRVO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 0.00
CRVO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CRVO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -6616275.00
CRVO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 20456.00
CRVO balance_sheet (quarterly, 2025-06-30) — Working Capital: 33439779.00
CRVO income_statement (quarterly, 2025-09-30) — +Operating Expense: 8044199.00
CRVO income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
CRVO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1349219.00
CRVO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 115606949.00
CRVO cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -221525.00
CRVO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 9252719.00
CRVO income_statement (quarterly, 2025-09-30) — Basic EPS: -0.84
CRVO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 8320713.00
CRVO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 9252.00
CRVO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 9437400.00
CRVO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 27294088.00
CRVO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 0.00
CRVO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 7581897.00
CRVO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -6465210.00
CRVO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -434813.00
CRVO cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 454084.00
CRVO cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -105977.00
CRVO cash_flow (quarterly, 2025-09-30) — Change In Payable: -434813.00
CRVO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 19271.00
CRVO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 278355.00
CRVO cash_flow (quarterly, 2025-09-30) — Change In Receivables: 999588.00
CRVO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1191237.00
CRVO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 1116687.00
CRVO balance_sheet (quarterly, 2025-09-30) — Common Stock: 9252.00
CRVO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 26011464.00
CRVO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
CRVO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 2113219.00
CRVO balance_sheet (quarterly, 2025-09-30) — Current Assets: 30610778.00
CRVO balance_sheet (quarterly, 2025-09-30) — Current Deferred Assets: 269331.00
CRVO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 4599314.00
CRVO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 9252719.00
CRVO income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.84
CRVO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -7726639.00
CRVO income_statement (quarterly, 2025-09-30) — EBIT: -8044199.00
CRVO income_statement (quarterly, 2025-09-30) — EBITDA: -8044199.00
CRVO cash_flow (quarterly, 2025-09-30) — End Cash Position: 9437400.00
CRVO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 0.00
CRVO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -6465210.00
CRVO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 5824.00
CRVO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 2326326.00
CRVO income_statement (quarterly, 2025-09-30) — Interest Income: 318787.00
CRVO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 318787.00
CRVO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 26011464.00
CRVO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 7581897.00
CRVO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CRVO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CRVO income_statement (quarterly, 2025-09-30) — Net Income: -7726639.00
CRVO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -7726639.00
CRVO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -7726639.00
CRVO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -7726639.00
CRVO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -7726639.00
CRVO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -7726639.00
CRVO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -7726639.00
CRVO income_statement (quarterly, 2025-09-30) — Net Interest Income: 318787.00
CRVO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 7581897.00
CRVO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 318787.00
CRVO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 26011464.00
CRVO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -8044199.00
CRVO income_statement (quarterly, 2025-09-30) — Normalized Income: -7726639.00
CRVO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -6465210.00
CRVO income_statement (quarterly, 2025-09-30) — Operating Income: -8044199.00
CRVO income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
CRVO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 9252719.00
CRVO balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 94236.00
CRVO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 5824.00
CRVO income_statement (quarterly, 2025-09-30) — Other Gand A: 2326326.00
CRVO income_statement (quarterly, 2025-09-30) — Other Income Expense: -1227.00
CRVO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -1227.00
CRVO income_statement (quarterly, 2025-09-30) — Other Operating Expenses: -322569.00
CRVO balance_sheet (quarterly, 2025-09-30) — Other Receivables: 1361387.00
CRVO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 17856688.00
CRVO balance_sheet (quarterly, 2025-09-30) — Payables: 1379675.00
CRVO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 3492894.00
CRVO balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 1012184.00
CRVO balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CRVO balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 1685972.00
CRVO income_statement (quarterly, 2025-09-30) — Pretax Income: -7726639.00
CRVO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -3918103.00
CRVO balance_sheet (quarterly, 2025-09-30) — Receivables: 1361387.00
CRVO income_statement (quarterly, 2025-09-30) — Research And Development: 6040442.00
CRVO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -89610561.00